The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 22, 2017
Filed:
Mar. 31, 2014
Applicant:
Kaohsiung Medical University, Kaohsiung, TW;
Inventors:
Chia-Yen Dai, Kaohsiung, TW;
Ming-Lung Yu, Kaohsiung, TW;
Wan-Long Chuang, Kaohsiung, TW;
Wen-Wen Chou, Kaohsiung, TW;
Assignee:
KAOHSIUNG MEDICAL UNIVERSITY, Kaohsiung, TW;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/7105 (2006.01); G01N 33/576 (2006.01); G01N 33/50 (2006.01); A61K 38/21 (2006.01); C12Q 1/68 (2006.01); C12Q 1/70 (2006.01); A61K 31/7056 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/707 (2013.01); A61K 31/7056 (2013.01); A61K 38/21 (2013.01); G01N 33/5767 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/178 (2013.01);
Abstract
A method for evaluating the therapeutic efficacy of interferon (IFN)/ribavirin (RBV) for hepatitis C is disclosed. The method includes the steps of providing a specimen; mixing the specimen, a primer of a miRNA Let-7g and a poly-chain reaction (PCR) reagent together; and evaluating the efficacy of IFN/RBV on inhibiting a hepatitis C virus according to the expressing level of the miRNA Let-7g in the specimen detected by the PCR reagent.